We are pleased to announce the founding of SIMPLIVIA HEALTHCARE LTD. As of May 1st, the company incorporates the Tevadaptor® global business and manufacturing activity.
Simplivia™ was acquired by FIMI opportunity fund - one of the top 5 investment funds in the world in terms of consistency of performance.
Mr. Ori Yehudai, former CEO of flavors and spices company Frutarom, sold for $6.5 billion last year, has joined the company as an active chairman.
Mr. Oded Grinstein, formerly the Tevadaptor® global BU general manager, was appointed as the CEO of the company.
We strongly believe that this is an exceptional vote of confidence and a great opportunity for the business to grow. We do expect not just good but great things!
As always, our customers are our first priority. We are committed to them and will act to ensure that their needs are met.
Tevadaptor®, now a Simplivia™ product, will continue to keep our healthcare professionals safe!